ArticleCancers2021

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC).

Qi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.